HIF-1alpha, a Survival and Differentiation Factor for Cartilage

HIF-1alpha,软骨的存活和分化因子

基本信息

  • 批准号:
    8609400
  • 负责人:
  • 金额:
    $ 34.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-26 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Oxygen (O2) is not only an indispensable metabolic substrate in various enzymatic reactions including mitochondrial respiration, but also a regulatory signal that controls stability and activity of !"#$transcription factor Hypoxia Inducible Factor-1¿ (HIF-1¿), a key mediator of the cellular adaptation to low O2 tension (hypoxia). The fetal growth plate is a unique mesenchymal tissue because it is avascular, albeit it requires the angiogenic switch in order to be replaced by bone. Over the years, we have demonstrated that, consistent with its avascularity, the fetal growth plate has an inner hypoxic region. We have provided genetic evidence that HIF-1¿ is a survival factor for hypoxic chondrocytes in vivo. We have shown that mesenchymal condensations of the limb bud are also hypoxic, and lack of HIF-1¿ in limb bud mesenchyme delays differentiation of mesenchymal cells into chondrocytes in vivo. In this grant, we propose to identify the molecular mechanisms that mediate the role of HIF-1¿ as a survival and differentiation factor in cartilage in vivo. Along these lines, we have reported that viable chondrocytes at the periphery of HIF-1¿ null growth plates and HIF-1¿ null mesenchymal condensations of the limb bud are considerably more hypoxic than controls. Moreover, we have provided genetic evidence that the extreme hypoxia of HIF-1¿ null cells is not the consequence of reduced availability of O2 to the growth plate. Therefore, we hypothesized it had to be the consequence of increased O2 consumption. Our hypothesis is in line with the well- documented ability of HIF-1¿ to impair mitochondrial respiration in vitro. Based on these findings, we now propose that a key function of HIF-1¿ is to reduce O2 consumption in cells that are already hypoxic because of limited availability of O2, in order to prevent them from becoming virtually anoxic, a status that is not compatible with cell survival and differentiation. Specifically, we hypothesize that HIF-1¿ is essential for survival of hypoxic chondrocytes and for timely differentiation of hypoxic mesenchymal cells into chondrocytes by negatively regulating mitochondrial respiration, and thus mitochondrial O2 consumption. We will test our hypothesis by inhibiting mitochondrial respiration in HIF-1¿ null chondrocytes (Specific Aim I) and in HIF-1¿ null mesenchymal cells of the limb bud (Specific Aim II) in vivo and in vitro. Moreover, we will establish whether HIF-1¿ lowers O2 consumption in chondrocytes in vitro (Specific Aim III). Our findings may lead to a paradigm shift if we determine that, differently from what has been reported in the context of well-oxygenated tissues, impairment of mitochondrial respiration is an indispensable requirement for survival and for early differentiation stages of hypoxic chondrocytes. $
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amato J. Giaccia其他文献

Benzamides substitués et leurs utilisations
苯甲酰胺替代品和用途
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Bonnet;Denise A. Chan;Amato J. Giaccia;Michael Patrick Hay;Edwin W. Lai;Olga V. Razorenova;Connie Sun;Ray Tabibiazar;Po
  • 通讯作者:
    Po
88: Lysyl Oxidase Is Essential for Hypoxia-Induced Metastasis
  • DOI:
    10.1016/j.ijrobp.2006.07.118
  • 发表时间:
    2006-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Janine Erler;Quynh Le;Amato J. Giaccia
  • 通讯作者:
    Amato J. Giaccia
Lysyl oxidase is essential for hypoxia-induced metastasis
赖氨酰氧化酶对于缺氧诱导的转移是必不可少的
  • DOI:
    10.1038/nature04695
  • 发表时间:
    2006-04-27
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Janine T. Erler;Kevin L. Bennewith;Monica Nicolau;Nadja Dornhöfer;Christina Kong;Quynh-Thu Le;Jen-Tsan Ashley Chi;Stefanie S. Jeffrey;Amato J. Giaccia
  • 通讯作者:
    Amato J. Giaccia
Hypoxic gene expression and metastasis
  • DOI:
    10.1023/b:canc.0000031768.89246.d7
  • 发表时间:
    2004-08-01
  • 期刊:
  • 影响因子:
    8.700
  • 作者:
    Quynh-Thu Le;Nicholas C. Denko;Amato J. Giaccia
  • 通讯作者:
    Amato J. Giaccia
Therapeutic targeting of the functionally elusive TAM receptor family
对功能上难以捉摸的 TAM 受体家族的治疗靶向
  • DOI:
    10.1038/s41573-023-00846-8
  • 发表时间:
    2023-12-13
  • 期刊:
  • 影响因子:
    101.800
  • 作者:
    Yu Rebecca Miao;Erinn B. Rankin;Amato J. Giaccia
  • 通讯作者:
    Amato J. Giaccia

Amato J. Giaccia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amato J. Giaccia', 18)}}的其他基金

Project 1: Inhibition of Complement C5aR1 Radioprotects Normal Tissue and Radiosensitizes Tumors
项目 1:抑制补体 C5aR1 辐射保护正常组织并使肿瘤辐射增敏
  • 批准号:
    10707880
  • 财政年份:
    2022
  • 资助金额:
    $ 34.65万
  • 项目类别:
Project 1: Inhibition of Complement C5aR1 Radioprotects Normal Tissue and Radiosensitizes Tumors
项目 1:抑制补体 C5aR1 辐射保护正常组织并使肿瘤辐射增敏
  • 批准号:
    10334199
  • 财政年份:
    2022
  • 资助金额:
    $ 34.65万
  • 项目类别:
Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer
针对晚期肾癌 AXL 的新疗法的临床前测试
  • 批准号:
    8949353
  • 财政年份:
    2016
  • 资助金额:
    $ 34.65万
  • 项目类别:
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
HIF 抑制线粒体和脂质积累对肿瘤生长的影响
  • 批准号:
    10212325
  • 财政年份:
    2015
  • 资助金额:
    $ 34.65万
  • 项目类别:
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
HIF 抑制线粒体和脂质积累对肿瘤生长的影响
  • 批准号:
    9976465
  • 财政年份:
    2015
  • 资助金额:
    $ 34.65万
  • 项目类别:
Administration & Scientific Support
行政
  • 批准号:
    8208647
  • 财政年份:
    2011
  • 资助金额:
    $ 34.65万
  • 项目类别:
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
缺氧和 CTGF 对肿瘤和转移性生长的调节
  • 批准号:
    8492949
  • 财政年份:
    2011
  • 资助金额:
    $ 34.65万
  • 项目类别:
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
缺氧和 CTGF 对肿瘤和转移性生长的调节
  • 批准号:
    8208641
  • 财政年份:
    2011
  • 资助金额:
    $ 34.65万
  • 项目类别:
Radiation Biology
放射生物学
  • 批准号:
    8180970
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
Postdoctoral Training in the Radiation Sciences
放射科学博士后培训
  • 批准号:
    7233332
  • 财政年份:
    2007
  • 资助金额:
    $ 34.65万
  • 项目类别:

相似国自然基金

线粒体应激促进肿瘤第一条新生血管(Angiogenic Switch)生成的作用机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Mechanisms of Angiogenic Switch Activation During Wound Repair
伤口修复过程中血管生成开关激活的机制
  • 批准号:
    8605544
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
Mechanisms of Angiogenic Switch Activation During Wound Repair
伤口修复过程中血管生成开关激活的机制
  • 批准号:
    8214637
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
Mechanisms of Angiogenic Switch Activation During Wound Repair
伤口修复过程中血管生成开关激活的机制
  • 批准号:
    7781877
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
Mechanisms of Angiogenic Switch Activation During Wound Repair
伤口修复过程中血管生成开关激活的机制
  • 批准号:
    8015578
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
Mechanisms of Angiogenic Switch Activation During Wound Repair
伤口修复过程中血管生成开关激活的机制
  • 批准号:
    8426148
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
Physicochemical Cues and Their Roles in the Angiogenic Switch
物理化学线索及其在血管生成开关中的作用
  • 批准号:
    7796233
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
Is Hypoxia Inducible Factor 2 the Trigger of the Angiogenic Switch and a Driver of Disease Progression in Myeloma?
缺氧诱导因子 2 是血管生成开关的触发因素和骨髓瘤疾病进展的驱动因素吗?
  • 批准号:
    nhmrc : 626911
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
    NHMRC Project Grants
Critical role of TGF-beta for tumor angiogenic switch
TGF-β 对肿瘤血管生成开关的关键作用
  • 批准号:
    21791243
  • 财政年份:
    2009
  • 资助金额:
    $ 34.65万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Regulation of the anti-angiogenic switch by CD36, Thrombospondin, and HRGP
CD36、血小板反应蛋白和 HRGP 调节抗血管生成开关
  • 批准号:
    7524585
  • 财政年份:
    2008
  • 资助金额:
    $ 34.65万
  • 项目类别:
Methyl selenium regulation of Angiogenic switch Mech
甲基硒对血管生成开关机制的调节
  • 批准号:
    6702564
  • 财政年份:
    2003
  • 资助金额:
    $ 34.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了